These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 32855361)

  • 1. Clinical characteristics of chronic liver disease with coronavirus disease 2019 (COVID-19): a cohort study in Wuhan, China.
    Li C; Chen Q; Wang J; Lin H; Lin Y; Lin J; Peng F; Chen J; Yang Z
    Aging (Albany NY); 2020 Aug; 12(16):15938-15945. PubMed ID: 32855361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver damage at admission is an independent prognostic factor for COVID-19.
    Chen LY; Chu HK; Bai T; Tu SJ; Wei Y; Li ZL; Hu LL; Zhu R; Zhang L; Han CQ; Xiao L; He Q; Song J; Liu WH; Zhu QJ; Chen H; Yang L; Hou XH
    J Dig Dis; 2020 Sep; 21(9):512-518. PubMed ID: 32713118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre.
    Wang X; Li X; Shang Y; Wang J; Zhang X; Su D; Zhao S; Wang Q; Liu L; Li Y; Chen H
    Epidemiol Infect; 2020 Sep; 148():e211. PubMed ID: 32900409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19.
    Liu Y; Du X; Chen J; Jin Y; Peng L; Wang HHX; Luo M; Chen L; Zhao Y
    J Infect; 2020 Jul; 81(1):e6-e12. PubMed ID: 32283162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China.
    Wang M; Yan W; Qi W; Wu D; Zhu L; Li W; Wang X; Ma K; Ni M; Xu D; Wang H; Chen G; Yu H; Ding H; Xing M; Han M; Luo X; Chen T; Guo W; Xi D; Ning Q
    Hepatol Int; 2020 Sep; 14(5):723-732. PubMed ID: 33026573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
    Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L
    Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.
    Liu J; Liu Y; Xiang P; Pu L; Xiong H; Li C; Zhang M; Tan J; Xu Y; Song R; Song M; Wang L; Zhang W; Han B; Yang L; Wang X; Zhou G; Zhang T; Li B; Wang Y; Chen Z; Wang X
    J Transl Med; 2020 May; 18(1):206. PubMed ID: 32434518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nomogram for predicting mortality in patients with COVID-19 and solid tumors: a multicenter retrospective cohort study.
    Liu C; Li L; Song K; Zhan ZY; Yao Y; Gong H; Chen Y; Wang Q; Dong X; Xie Z; Ou CQ; Hu Q; Song Q
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32895296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neutrophil to lymphocyte ratio as a prognostic marker in COVID-19].
    Basbus L; Lapidus MI; Martingano I; Puga MC; Pollán J
    Medicina (B Aires); 2020; 80 Suppl 3():31-36. PubMed ID: 32658845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis.
    Li X; Liu C; Mao Z; Xiao M; Wang L; Qi S; Zhou F
    Crit Care; 2020 Nov; 24(1):647. PubMed ID: 33198786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
    Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
    Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
    Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
    Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis models for severe and critical COVID-19 based on the Charlson and Elixhauser comorbidity indices.
    Zhou W; Qin X; Hu X; Lu Y; Pan J
    Int J Med Sci; 2020; 17(15):2257-2263. PubMed ID: 32922189
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China.
    Zhang J; Wang X; Jia X; Li J; Hu K; Chen G; Wei J; Gong Z; Zhou C; Yu H; Yu M; Lei H; Cheng F; Zhang B; Xu Y; Wang G; Dong W
    Clin Microbiol Infect; 2020 Jun; 26(6):767-772. PubMed ID: 32304745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of familial clustering in patients infected with 2019 novel coronavirus in Wuhan, China.
    Li J; Gong X; Wang Z; Chen R; Li T; Zeng D; Li M
    Virus Res; 2020 Sep; 286():198043. PubMed ID: 32502551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China.
    Hu X; Hu C; Yang Y; Chen J; Zhong P; Wen Y; Chen X
    Ther Adv Respir Dis; 2020; 14():1753466620963035. PubMed ID: 33138694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can COVID-19 Mortality be Predicted in the Emergency Room?
    Güneysu F; Guner NG; Erdem AF; Durmus E; Durgun Y; Yurumez Y
    J Coll Physicians Surg Pak; 2020 Sep; 30(9):928-932. PubMed ID: 33036676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of coronavirus disease 2019 in Gansu province, China.
    Yue H; Bai X; Wang J; Yu Q; Liu W; Pu J; Wang X; Hu J; Xu D; Li X; Kang N; Li L; Lu W; Feng T; Ding L; Li X; Qi X;
    Ann Palliat Med; 2020 Jul; 9(4):1404-1412. PubMed ID: 32692208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.
    Zheng Y; Zhang Y; Chi H; Chen S; Peng M; Luo L; Chen L; Li J; Shen B; Wang D
    Clin Chem Lab Med; 2020 Jun; 58(7):1106-1115. PubMed ID: 32352397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study).
    Sarin SK; Choudhury A; Lau GK; Zheng MH; Ji D; Abd-Elsalam S; Hwang J; Qi X; Cua IH; Suh JI; Park JG; Putcharoen O; Kaewdech A; Piratvisuth T; Treeprasertsuk S; Park S; Wejnaruemarn S; Payawal DA; Baatarkhuu O; Ahn SH; Yeo CD; Alonzo UR; Chinbayar T; Loho IM; Yokosuka O; Jafri W; Tan S; Soo LI; Tanwandee T; Gani R; Anand L; Esmail ES; Khalaf M; Alam S; Lin CY; Chuang WL; Soin AS; Garg HK; Kalista K; Batsukh B; Purnomo HD; Dara VP; Rathi P; Al Mahtab M; Shukla A; Sharma MK; Omata M;
    Hepatol Int; 2020 Sep; 14(5):690-700. PubMed ID: 32623632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.